Stem-Cell Drug Developer PrimeGen Inks $1.5B SPAC Merger
By Al Barbarino · February 4, 2026, 6:08 PM EST
Regenerative medicine developer PrimeGen US said Wednesday it has agreed to go public through a merger with blank check company DT Cloud Star Acquisition Corp., in a deal that values the...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login